Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets close in 4 hours 2 minutes
Straits Times Index
3,316.63
+8.73
(+0.26%)
Nikkei
39,064.35
+447.25
(+1.16%)
Hang Seng
18,930.02
-265.58
(-1.38%)
FTSE 100
8,370.33
-46.12
(-0.55%)
Bitcoin USD
69,504.86
+39.95
(+0.06%)
CMC Crypto 200
1,514.46
-11.96
(-0.78%)
Argent BioPharma Limited (MGCLF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.2675
+0.0075
(+2.88%)
At close: 09:59AM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
4,732
3,388
4,732
2,963
2,079
-
Cost of revenue
2,922
1,937
2,922
1,652
1,905
-
Gross profit
1,810
1,451
1,810
1,310
174.665
-
Operating expenses
Research development
1,608
1,993
-
-
-
2,866
Selling general and administrative
10,312
13,059
10,312
6,313
4,308
-
Total operating expenses
16,071
17,049
16,071
13,380
11,979
-
Operating income or loss
-14,261
-15,598
-14,261
-12,070
-11,805
-
Interest expense
210.142
257.403
210.142
369.135
135.582
-
Total other income/expenses net
-6,297
-5,276
-6,297
-3,005
-6,842
-
Income before tax
-20,768
-21,132
-20,768
-15,437
-18,770
-
Income tax expense
0
2.018
0
-27.278
0
-
Income from continuing operations
-20,768
-21,134
-20,768
-15,409
-18,770
-
Net income
-20,347
-20,824
-20,347
-15,870
-19,363
-
Net income available to common shareholders
-20,347
-20,824
-20,347
-15,870
-19,363
-
Basic EPS
-7.10
-7.10
-7.90
-8.30
-14.00
-
Diluted EPS
-7.10
-7.10
-7.90
-8.30
-14.00
-
Basic average shares
2,947
2,947
2,566
1,906
1,382
-
Diluted average shares
2,947
2,947
2,566
1,906
1,382
-
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.